Aprin Pharmed



The most common and effective radiopharmaceutical for the diagnosis of prostate cancer is PSMA-11 labelled with a gallium radioisotope and it is widely used in PET scan imaging centers.

CAS registration number
  • 1366302-52-4
Molecular weight
  • 947.005 g/mol
molecular formula
  • C44H62N6O17
  • white powder
  • -20 C in a dry and dark environment
Therapeutic applications
  • Positron Emission Tomography (PET) imaging or radionuclide therapy